Publications:270
- Mount Sinai Doctors
Panagiotis Roussos, MD, MS, PhD
Psychiatry
No Patient Experience Ratings
About Me
Panos Roussos is a Professor of Psychiatry and Genetics and Genomic Sciences, a member of the Friedman Brain Institute and the Director of the Center for Disease Neurogenomics at the Icahn School of Medicine at Mount Sinai. He is also a VA/MIRECC Research Physician at the James J. Peters VA Medical Center.
Panos Roussos received his medical and doctorate degrees from the University of Crete in Greece. He completed his residency in Psychiatry (research track) at Icahn School of Medicine at Mount Sinai followed by a MIRECC research fellowship in schizophrenia.
Language
English
Position
PROFESSOR | Genetics and Genomic Sciences, PROFESSOR | Psychiatry, PROFESSOR | Artificial Intelligence and Human Health
Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
Research Topics
Alzheimer's Disease, Bioinformatics, Brain, Cerebral Cortex, Chromatin, Computational Biology, Epigenetics, Gene Expressions, Gene Regulation, Genetics, Genomics, Microarray, Neurobiology, Neuroscience, Prefrontal Cortex, Schizophrenia, Systems Biology
Multi-Disciplinary Training Areas
Genetics and Genomic Sciences [GGS], Neuroscience [NEU]
Education
MD, University of Crete
MD, University of Crete
MS, University of Crete
PhD, University of Crete
Residency, Icahn School of Medicine at Mount Sinai
Residency, Psychiatry
Mount Sinai Hospital
Awards
2020
Eva King Killam Research Award
American College of Neuropsychopharmacology
2019
Scientific Award in Life Sciences (Biomedical Sciences)
Bodossakis Foundation
2019
Rising Star Award, Rising Star Award
Congress of the Schizophrenia International Research Society
2016
Presidential Early Career Awards for Scientists and Engineers
White House
2013
Young Investor Award
NARSAD
2012
Early Academic Career Award
APA/Merck
2010
Outstanding Resident Award
National Institute of Mental Health
Research
Panos Roussos's research is focused on precision psychiatry by identifying the genetic variants and underlying mechanisms that cause disease and, ultimately, enabling personalized therapy.
Visit our website: https://icahn.mssm.edu/research/neurogenomics/ and https://labs.icahn.mssm.edu/roussos-lab/
Visit our website: https://icahn.mssm.edu/research/neurogenomics/ and https://labs.icahn.mssm.edu/roussos-lab/
Insurance Information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Functional implications of polygenic risk for schizophrenia in human neurons. P. J. Michael Deans, Kayla G. Retallick-Townsley, Aiqun Li, Carina Seah, Jessica Johnson, Judit Garcia Gonzalez, Evan Cao, Nadine Schrode, Alex Yu, Sam Cartwright, Georgios Voloudakis, Wen Zhang, Minghui Wang, John F. Fullard, Kiran Girdhar, Eli Stahl, Schahram Akbarian, Bin Zhang, Panos Roussos, Paul O’Reilly, Laura M. Huckins, Kristen J. Brennand. Nature Communications
- Dynamic Alterations in the Blood Transcriptome Characterize Drug Use Behavior and Co-Morbidities in Cocaine Use Disorder: A Preliminary Study. Chinwe Nwaneshiudu, Kiran Girdhar, Steven P Kleopoulos, Zhiping Shao, John F Fullard, Eduardo R Butelman, Muhammad A Parvaz, Rita Z Goldstein, Nelly Alia-Klein, Panos Roussos. European Journal of Neuroscience
- Multisite, Multiancestry Genome-Wide Association Study Meta-Analysis of Functional Seizure Disorder in a Hospital Sample of 675,680 Patients. Slavina B. Goleva, Costin Leu, Yen Chen Anne Feng, David Burstein, Sanan Venkatesh, Rebecca Birnbaum, Veera M. Rajagopal, Peter Straub, Jakob Christensen, Jocelyn F. Bautista, Robyn M. Busch, Imad M. Najm, Jakob Grove, Anders D. Børglum, Georgios Voloudakis, Panos Roussos, Jordan Smoller, Dennis Lal, Lea K. Davis. Biological Psychiatry Global Open Science
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Roussos has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.